

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.10111231 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.10111231 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.79348277 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.79348277 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.40180813 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.11597962 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.79717369 |
| 8 | tryptophan catabolic process (GO:0006569) | 5.79661019 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.79661019 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.79661019 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.77562331 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.70910042 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.64265749 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.46958181 |
| 15 | urea metabolic process (GO:0019627) | 5.37639186 |
| 16 | urea cycle (GO:0000050) | 5.37639186 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.22929552 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.19652694 |
| 19 | cysteine metabolic process (GO:0006534) | 5.13102593 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.11603145 |
| 21 | complement activation, alternative pathway (GO:0006957) | 5.07946120 |
| 22 | protein carboxylation (GO:0018214) | 5.05707035 |
| 23 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.05707035 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.05611995 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.04636673 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.03822198 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.97591396 |
| 28 | lysine metabolic process (GO:0006553) | 4.96857294 |
| 29 | lysine catabolic process (GO:0006554) | 4.96857294 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.94818843 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 4.92022161 |
| 32 | bile acid metabolic process (GO:0008206) | 4.91087499 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.84536541 |
| 34 | exogenous drug catabolic process (GO:0042738) | 4.70465627 |
| 35 | regulation of complement activation (GO:0030449) | 4.69823686 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.68160863 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.64675619 |
| 38 | cellular ketone body metabolic process (GO:0046950) | 4.61337991 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.60173519 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.59518099 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.56393684 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 4.56393684 |
| 43 | macromolecular complex remodeling (GO:0034367) | 4.56393684 |
| 44 | triglyceride homeostasis (GO:0070328) | 4.55973045 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.55973045 |
| 46 | alpha-amino acid catabolic process (GO:1901606) | 4.52824754 |
| 47 | tyrosine metabolic process (GO:0006570) | 4.48273770 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.35922930 |
| 49 | phospholipid efflux (GO:0033700) | 4.35054258 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 4.32004546 |
| 51 | sulfation (GO:0051923) | 4.31752538 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.29025708 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.29025708 |
| 54 | bile acid and bile salt transport (GO:0015721) | 4.24782298 |
| 55 | coenzyme catabolic process (GO:0009109) | 4.23994110 |
| 56 | flavonoid metabolic process (GO:0009812) | 4.22290399 |
| 57 | cellular amino acid catabolic process (GO:0009063) | 4.19752342 |
| 58 | cellular glucuronidation (GO:0052695) | 4.19132664 |
| 59 | glycine metabolic process (GO:0006544) | 4.12644389 |
| 60 | ethanol oxidation (GO:0006069) | 4.12602749 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.09926924 |
| 62 | glutamate metabolic process (GO:0006536) | 4.09475651 |
| 63 | acetyl-CoA metabolic process (GO:0006084) | 4.05978489 |
| 64 | short-chain fatty acid metabolic process (GO:0046459) | 4.04969953 |
| 65 | cholesterol efflux (GO:0033344) | 4.04238084 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 3.99937965 |
| 67 | amine catabolic process (GO:0009310) | 3.99937965 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 3.99271951 |
| 69 | ketone body metabolic process (GO:1902224) | 3.98913779 |
| 70 | serine family amino acid metabolic process (GO:0009069) | 3.96002637 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.94709037 |
| 72 | cellular modified amino acid catabolic process (GO:0042219) | 3.94337713 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93620385 |
| 74 | benzene-containing compound metabolic process (GO:0042537) | 3.93061219 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.92661806 |
| 76 | fatty acid oxidation (GO:0019395) | 3.88767050 |
| 77 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.88765384 |
| 78 | plasma lipoprotein particle assembly (GO:0034377) | 3.86593246 |
| 79 | cell proliferation in forebrain (GO:0021846) | 3.86381499 |
| 80 | drug catabolic process (GO:0042737) | 3.85781377 |
| 81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85710986 |
| 82 | organic acid catabolic process (GO:0016054) | 3.85049104 |
| 83 | carboxylic acid catabolic process (GO:0046395) | 3.85049104 |
| 84 | lipid oxidation (GO:0034440) | 3.81740903 |
| 85 | monocarboxylic acid catabolic process (GO:0072329) | 3.81732467 |
| 86 | carnitine metabolic process (GO:0009437) | 3.80819075 |
| 87 | fatty acid catabolic process (GO:0009062) | 3.78910950 |
| 88 | serotonin metabolic process (GO:0042428) | 3.77530077 |
| 89 | negative regulation of lipase activity (GO:0060192) | 3.76738450 |
| 90 | fibrinolysis (GO:0042730) | 3.75643861 |
| 91 | arginine metabolic process (GO:0006525) | 3.73943750 |
| 92 | aspartate family amino acid catabolic process (GO:0009068) | 3.73574488 |
| 93 | cellular response to ATP (GO:0071318) | 3.73318253 |
| 94 | 2-oxoglutarate metabolic process (GO:0006103) | 3.72699123 |
| 95 | cholesterol homeostasis (GO:0042632) | 3.71952615 |
| 96 | glucuronate metabolic process (GO:0019585) | 3.71933890 |
| 97 | uronic acid metabolic process (GO:0006063) | 3.71933890 |
| 98 | * positive regulation of lipid catabolic process (GO:0050996) | 3.69827580 |
| 99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.69430934 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67436227 |
| 101 | aldehyde catabolic process (GO:0046185) | 3.66903644 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.66121904 |
| 103 | sterol homeostasis (GO:0055092) | 3.66061572 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65484583 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65484583 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.62707591 |
| 107 | primary amino compound metabolic process (GO:1901160) | 3.62391739 |
| 108 | cofactor catabolic process (GO:0051187) | 3.59832778 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59637284 |
| 110 | epoxygenase P450 pathway (GO:0019373) | 3.59409774 |
| 111 | oxidative demethylation (GO:0070989) | 3.49497884 |
| 112 | gamma-aminobutyric acid transport (GO:0015812) | 3.46307522 |
| 113 | otic vesicle formation (GO:0030916) | 3.46259589 |
| 114 | indole-containing compound metabolic process (GO:0042430) | 3.41662433 |
| 115 | opsonization (GO:0008228) | 3.41555619 |
| 116 | cellular anion homeostasis (GO:0030002) | 3.38780821 |
| 117 | regulation of skeletal muscle contraction (GO:0014819) | 3.37528465 |
| 118 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.32078894 |
| 119 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.25302088 |
| 120 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.24275454 |
| 121 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.20128525 |
| 122 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.20128525 |
| 123 | omega-hydroxylase P450 pathway (GO:0097267) | 3.12764370 |
| 124 | membrane repolarization during action potential (GO:0086011) | 3.12344717 |
| 125 | regulation of membrane repolarization (GO:0060306) | 3.11254470 |
| 126 | negative regulation of protein localization to cell surface (GO:2000009) | 3.04433991 |
| 127 | * behavioral response to nicotine (GO:0035095) | 3.02624889 |
| 128 | drug metabolic process (GO:0017144) | 2.97603025 |
| 129 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.97241398 |
| 130 | alkaloid metabolic process (GO:0009820) | 2.90234002 |
| 131 | * positive regulation of fatty acid oxidation (GO:0046321) | 2.89635845 |
| 132 | parturition (GO:0007567) | 2.83068701 |
| 133 | plasma membrane repair (GO:0001778) | 2.81634111 |
| 134 | regulation of action potential (GO:0098900) | 2.76731751 |
| 135 | somite development (GO:0061053) | 2.74731621 |
| 136 | response to inactivity (GO:0014854) | 2.74452283 |
| 137 | membrane depolarization during action potential (GO:0086010) | 2.73353778 |
| 138 | vitamin biosynthetic process (GO:0009110) | 2.72860936 |
| 139 | regulation of glomerulus development (GO:0090192) | 2.72228121 |
| 140 | pharyngeal system development (GO:0060037) | 2.64852466 |
| 141 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.58631643 |
| 142 | positive regulation of fatty acid transport (GO:2000193) | 2.57733084 |
| 143 | vitamin catabolic process (GO:0009111) | 2.53252427 |
| 144 | fat-soluble vitamin catabolic process (GO:0042363) | 2.53252427 |
| 145 | regulation of hippo signaling (GO:0035330) | 2.52179665 |
| 146 | response to muscle activity (GO:0014850) | 2.48690717 |
| 147 | cellular response to exogenous dsRNA (GO:0071360) | 2.47000234 |
| 148 | heme transport (GO:0015886) | 2.46128278 |
| 149 | multicellular organismal signaling (GO:0035637) | 2.42411845 |
| 150 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.39549126 |
| 151 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.38827503 |
| 152 | membrane repolarization (GO:0086009) | 2.36397864 |
| 153 | neuronal action potential (GO:0019228) | 2.36335111 |
| 154 | cardiac conduction (GO:0061337) | 2.33827545 |
| 155 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.32574982 |
| 156 | regulation of female receptivity (GO:0045924) | 2.32560160 |
| 157 | sarcomere organization (GO:0045214) | 2.31253586 |
| 158 | detection of light stimulus involved in visual perception (GO:0050908) | 2.30851460 |
| 159 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.30851460 |
| 160 | sulfate transmembrane transport (GO:1902358) | 2.30707510 |
| 161 | transmission of nerve impulse (GO:0019226) | 2.30469898 |
| 162 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.30432555 |
| 163 | ethanol metabolic process (GO:0006067) | 2.28979432 |
| 164 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.28342367 |
| 165 | interkinetic nuclear migration (GO:0022027) | 2.26890395 |
| 166 | myofibril assembly (GO:0030239) | 2.26589339 |
| 167 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.26243617 |
| 168 | lymphangiogenesis (GO:0001946) | 2.25892837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.11361485 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.98752814 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.55972263 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.37192809 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.79658606 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19200938 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.97778843 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70168531 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08364157 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59406661 |
| 11 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.72130500 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54477441 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.24952735 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07326321 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.04356145 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.03649029 |
| 17 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4231282 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98091471 |
| 19 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96681857 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87824450 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.84259379 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76981611 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.76447628 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.75192372 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.73581112 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71746081 |
| 27 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71040880 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.70423130 |
| 29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68827003 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.67687255 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65685427 |
| 32 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65111543 |
| 33 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61610812 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.58256917 |
| 35 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.53250260 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.53250260 |
| 37 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.52576938 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48625091 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48539964 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46627889 |
| 41 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.46624581 |
| 42 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.44034974 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43563355 |
| 44 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41288642 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40733151 |
| 46 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40171262 |
| 47 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39739940 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37910085 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37279157 |
| 50 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.35518066 |
| 51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34986838 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.34455138 |
| 53 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.33318382 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30133520 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27868015 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26302733 |
| 57 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25393840 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.23838016 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.23589634 |
| 60 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21214157 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19753650 |
| 62 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19073282 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18786137 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18398745 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18208095 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17878578 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.16124064 |
| 68 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15304774 |
| 69 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13489643 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12732283 |
| 71 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12547172 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12158026 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10603016 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10278576 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10278576 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08710987 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07901549 |
| 78 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07183089 |
| 79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05994814 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.05488002 |
| 81 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05488002 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05415295 |
| 83 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.05348767 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04570766 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04306697 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03830755 |
| 87 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.03144127 |
| 88 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02794250 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02211091 |
| 90 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01951782 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01227251 |
| 92 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00892905 |
| 93 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00246632 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99633815 |
| 95 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99071096 |
| 96 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98997533 |
| 97 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98563642 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.98518181 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.98447011 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98208616 |
| 101 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.98041339 |
| 102 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97597360 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97538786 |
| 104 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97420110 |
| 105 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.97066064 |
| 106 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96989784 |
| 107 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96836602 |
| 108 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96805578 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96751243 |
| 110 | KDM2B_26808549_Chip-Seq_REH_Human | 0.96168616 |
| 111 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.96008374 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.95535614 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94866851 |
| 114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93967252 |
| 115 | NCOR_22424771_ChIP-Seq_293T_Human | 0.93833583 |
| 116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93537002 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93193626 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92063260 |
| 119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91364631 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87969073 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.87560134 |
| 122 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85964683 |
| 123 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83881178 |
| 124 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79353373 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77341662 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77332786 |
| 127 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76546988 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76445985 |
| 129 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74332917 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72891682 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72891682 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70719832 |
| 133 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68501447 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67379842 |
| 135 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.67198813 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66247923 |
| 137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.65406852 |
| 138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65016443 |
| 139 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.64121262 |
| 140 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62565575 |
| 141 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62249838 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60960163 |
| 143 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59940392 |
| 144 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59082004 |
| 145 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.58762822 |
| 146 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57174189 |
| 147 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54909152 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54902286 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54364192 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54003896 |
| 151 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.53965607 |
| 152 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.52923051 |
| 153 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52641194 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.52390772 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.52371392 |
| 156 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52313067 |
| 157 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49865268 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49258551 |
| 159 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.49069786 |
| 160 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.49069786 |
| 161 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48258292 |
| 162 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48171051 |
| 163 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48087268 |
| 164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.47472484 |
| 165 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.47161331 |
| 166 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46898571 |
| 167 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.45754254 |
| 168 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.45519371 |
| 169 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45400720 |
| 170 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.43887049 |
| 171 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43744313 |
| 172 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.43236476 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42545752 |
| 174 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.42052203 |
| 175 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41922197 |
| 176 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.41870530 |
| 177 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40743748 |
| 178 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40236622 |
| 179 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39585667 |
| 180 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.38011853 |
| 181 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.37989527 |
| 182 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37820726 |
| 183 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.37336114 |
| 184 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37137211 |
| 185 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36500407 |
| 186 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36468450 |
| 187 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.34907484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.06585396 |
| 2 | MP0005360_urolithiasis | 7.36982355 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.36140665 |
| 4 | MP0005365_abnormal_bile_salt | 6.11266481 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.99615671 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.02102826 |
| 7 | MP0003252_abnormal_bile_duct | 3.89937983 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.78779832 |
| 9 | * MP0010329_abnormal_lipoprotein_level | 3.52057033 |
| 10 | MP0009840_abnormal_foam_cell | 3.11252003 |
| 11 | MP0005083_abnormal_biliary_tract | 3.02049659 |
| 12 | MP0005332_abnormal_amino_acid | 2.84582110 |
| 13 | MP0003195_calcinosis | 2.82146801 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.58520583 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.23543919 |
| 16 | * MP0002118_abnormal_lipid_homeostasis | 2.20642289 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.16716828 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.14916586 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.13694536 |
| 20 | MP0003879_abnormal_hair_cell | 2.10306029 |
| 21 | MP0002160_abnormal_reproductive_system | 1.97389441 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.88999969 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.86353335 |
| 24 | MP0006292_abnormal_olfactory_placode | 1.86014525 |
| 25 | MP0003868_abnormal_feces_composition | 1.86007858 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.83366102 |
| 27 | MP0009379_abnormal_foot_pigmentation | 1.73808864 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.67573282 |
| 29 | MP0004885_abnormal_endolymph | 1.66522064 |
| 30 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63863813 |
| 31 | MP0004142_abnormal_muscle_tone | 1.63572139 |
| 32 | MP0001764_abnormal_homeostasis | 1.59615796 |
| 33 | MP0005451_abnormal_body_composition | 1.53934961 |
| 34 | MP0005670_abnormal_white_adipose | 1.53825027 |
| 35 | MP0003011_delayed_dark_adaptation | 1.48067467 |
| 36 | MP0009697_abnormal_copulation | 1.47785935 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.45764400 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.32869898 |
| 39 | MP0002272_abnormal_nervous_system | 1.30813301 |
| 40 | MP0004134_abnormal_chest_morphology | 1.30563358 |
| 41 | MP0009643_abnormal_urine_homeostasis | 1.29665453 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.29344372 |
| 43 | MP0003186_abnormal_redox_activity | 1.25226139 |
| 44 | * MP0004215_abnormal_myocardial_fiber | 1.24904245 |
| 45 | MP0005389_reproductive_system_phenotype | 1.24423523 |
| 46 | MP0000049_abnormal_middle_ear | 1.21794602 |
| 47 | MP0002106_abnormal_muscle_physiology | 1.21111569 |
| 48 | MP0002638_abnormal_pupillary_reflex | 1.18456802 |
| 49 | MP0009745_abnormal_behavioral_response | 1.17459340 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.17306991 |
| 51 | MP0003705_abnormal_hypodermis_morpholog | 1.15699593 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.15055391 |
| 53 | MP0002733_abnormal_thermal_nociception | 1.13987716 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.12242777 |
| 55 | * MP0000598_abnormal_liver_morphology | 1.11923783 |
| 56 | MP0004036_abnormal_muscle_relaxation | 1.11437887 |
| 57 | MP0000678_abnormal_parathyroid_gland | 1.09665540 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.09349401 |
| 59 | MP0003136_yellow_coat_color | 1.09117925 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.08787592 |
| 61 | MP0005647_abnormal_sex_gland | 1.08371212 |
| 62 | MP0002254_reproductive_system_inflammat | 1.08325689 |
| 63 | MP0002971_abnormal_brown_adipose | 1.08139051 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.06530801 |
| 65 | MP0010368_abnormal_lymphatic_system | 1.05426815 |
| 66 | MP0000026_abnormal_inner_ear | 1.04982127 |
| 67 | MP0004085_abnormal_heartbeat | 1.04842830 |
| 68 | MP0002064_seizures | 1.01781335 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.01325564 |
| 70 | MP0009764_decreased_sensitivity_to | 1.01200182 |
| 71 | MP0005369_muscle_phenotype | 1.01091200 |
| 72 | MP0009250_abnormal_appendicular_skeleto | 1.00979153 |
| 73 | MP0000604_amyloidosis | 0.99529525 |
| 74 | MP0002249_abnormal_larynx_morphology | 0.99356144 |
| 75 | * MP0009763_increased_sensitivity_to | 0.96227515 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.95016982 |
| 77 | MP0001986_abnormal_taste_sensitivity | 0.94858530 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.94325141 |
| 79 | MP0002089_abnormal_postnatal_growth/wei | 0.93775406 |
| 80 | * MP0004130_abnormal_muscle_cell | 0.92132245 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 0.90905402 |
| 82 | MP0009046_muscle_twitch | 0.90898316 |
| 83 | MP0004484_altered_response_of | 0.90579664 |
| 84 | MP0000751_myopathy | 0.90366080 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.90108602 |
| 86 | MP0005535_abnormal_body_temperature | 0.90000395 |
| 87 | * MP0002078_abnormal_glucose_homeostasis | 0.89366358 |
| 88 | MP0001970_abnormal_pain_threshold | 0.89269618 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.88755762 |
| 90 | MP0000749_muscle_degeneration | 0.88471143 |
| 91 | MP0002653_abnormal_ependyma_morphology | 0.87323205 |
| 92 | MP0005386_behavior/neurological_phenoty | 0.87138092 |
| 93 | MP0004924_abnormal_behavior | 0.87138092 |
| 94 | MP0004133_heterotaxia | 0.86982478 |
| 95 | * MP0009642_abnormal_blood_homeostasis | 0.86493872 |
| 96 | MP0001486_abnormal_startle_reflex | 0.86008275 |
| 97 | MP0008469_abnormal_protein_level | 0.83332752 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.81759466 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.81062256 |
| 100 | MP0002163_abnormal_gland_morphology | 0.80753582 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.80212253 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.79805737 |
| 103 | * MP0005334_abnormal_fat_pad | 0.78322882 |
| 104 | MP0004742_abnormal_vestibular_system | 0.77038475 |
| 105 | MP0005377_hearing/vestibular/ear_phenot | 0.76725783 |
| 106 | MP0003878_abnormal_ear_physiology | 0.76725783 |
| 107 | MP0002972_abnormal_cardiac_muscle | 0.76478686 |
| 108 | MP0001661_extended_life_span | 0.76468927 |
| 109 | MP0002102_abnormal_ear_morphology | 0.76355574 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.76267639 |
| 111 | MP0006276_abnormal_autonomic_nervous | 0.75408020 |
| 112 | MP0005408_hypopigmentation | 0.73608494 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.72923101 |
| 114 | MP0002876_abnormal_thyroid_physiology | 0.72646186 |
| 115 | MP0005266_abnormal_metabolism | 0.72335881 |
| 116 | MP0006035_abnormal_mitochondrial_morpho | 0.72312264 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.72245267 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.71331964 |
| 119 | MP0002938_white_spotting | 0.70761960 |
| 120 | MP0009780_abnormal_chondrocyte_physiolo | 0.70663906 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69737270 |
| 122 | MP0002067_abnormal_sensory_capabilities | 0.69729886 |
| 123 | MP0002572_abnormal_emotion/affect_behav | 0.69334414 |
| 124 | MP0003690_abnormal_glial_cell | 0.68298326 |
| 125 | MP0003938_abnormal_ear_development | 0.67948317 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.66877584 |
| 127 | MP0001756_abnormal_urination | 0.65105059 |
| 128 | MP0004270_analgesia | 0.64938087 |
| 129 | * MP0005448_abnormal_energy_balance | 0.57054621 |
| 130 | MP0003329_amyloid_beta_deposits | 0.57020598 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.53376813 |
| 132 | MP0009115_abnormal_fat_cell | 0.52396476 |
| 133 | MP0002822_catalepsy | 0.51310059 |
| 134 | MP0009053_abnormal_anal_canal | 0.49865515 |
| 135 | MP0003724_increased_susceptibility_to | 0.49200812 |
| 136 | MP0002136_abnormal_kidney_physiology | 0.49011529 |
| 137 | MP0004185_abnormal_adipocyte_glucose | 0.49007713 |
| 138 | MP0003646_muscle_fatigue | 0.47229110 |
| 139 | MP0002970_abnormal_white_adipose | 0.46031233 |
| 140 | * MP0003953_abnormal_hormone_level | 0.45288529 |
| 141 | MP0005395_other_phenotype | 0.45248451 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.44374652 |
| 143 | MP0008874_decreased_physiological_sensi | 0.43211846 |
| 144 | MP0002928_abnormal_bile_duct | 0.41212026 |
| 145 | MP0003638_abnormal_response/metabolism_ | 0.41115734 |
| 146 | MP0002796_impaired_skin_barrier | 0.40398004 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.40348943 |
| 148 | MP0005464_abnormal_platelet_physiology | 0.39978722 |
| 149 | MP0008872_abnormal_physiological_respon | 0.39622918 |
| 150 | MP0004782_abnormal_surfactant_physiolog | 0.39334880 |
| 151 | MP0008873_increased_physiological_sensi | 0.39141513 |
| 152 | MP0004381_abnormal_hair_follicle | 0.37279614 |
| 153 | MP0004043_abnormal_pH_regulation | 0.36470734 |
| 154 | * MP0000230_abnormal_systemic_arterial | 0.36226244 |
| 155 | MP0005248_abnormal_Harderian_gland | 0.36187382 |
| 156 | MP0009672_abnormal_birth_weight | 0.35913721 |
| 157 | MP0002269_muscular_atrophy | 0.35861359 |
| 158 | MP0002168_other_aberrant_phenotype | 0.34854488 |
| 159 | MP0000579_abnormal_nail_morphology | 0.34583276 |
| 160 | MP0003718_maternal_effect | 0.33514683 |
| 161 | * MP0005330_cardiomyopathy | 0.33290537 |
| 162 | MP0003075_altered_response_to | 0.31869206 |
| 163 | MP0005166_decreased_susceptibility_to | 0.31371022 |
| 164 | MP0000249_abnormal_blood_vessel | 0.30955056 |
| 165 | MP0002090_abnormal_vision | 0.29583909 |
| 166 | MP0001881_abnormal_mammary_gland | 0.28210116 |
| 167 | MP0002060_abnormal_skin_morphology | 0.27253183 |
| 168 | MP0002332_abnormal_exercise_endurance | 0.26199748 |
| 169 | MP0006138_congestive_heart_failure | 0.25899220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.91573239 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.90616843 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.76085435 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.11592326 |
| 5 | Xanthomatosis (HP:0000991) | 6.10114654 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.08428716 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.04012035 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.28787818 |
| 9 | Complement deficiency (HP:0004431) | 4.99879416 |
| 10 | Hyperammonemia (HP:0001987) | 4.83488423 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.72472177 |
| 12 | Ketosis (HP:0001946) | 4.53207811 |
| 13 | Epidermoid cyst (HP:0200040) | 4.52813358 |
| 14 | Hyperglycinemia (HP:0002154) | 4.52220669 |
| 15 | Hyperglycinuria (HP:0003108) | 4.49915432 |
| 16 | Hypoglycemic coma (HP:0001325) | 4.43145413 |
| 17 | Joint hemorrhage (HP:0005261) | 4.42269816 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34799475 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31332174 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.31332174 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 4.28150951 |
| 22 | Genetic anticipation (HP:0003743) | 4.20605607 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.19038989 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.17085121 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.00545298 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 3.95792176 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92661506 |
| 28 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.90557760 |
| 29 | Fat malabsorption (HP:0002630) | 3.88754537 |
| 30 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.67836417 |
| 31 | Abnormality of complement system (HP:0005339) | 3.59743967 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57435671 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.54585945 |
| 34 | Progressive cerebellar ataxia (HP:0002073) | 3.52575903 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 3.50404768 |
| 36 | Decreased circulating renin level (HP:0003351) | 3.49806137 |
| 37 | Ketoacidosis (HP:0001993) | 3.46237928 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.39936473 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.23845003 |
| 40 | Confusion (HP:0001289) | 3.17427286 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.17208567 |
| 42 | Calf muscle hypertrophy (HP:0008981) | 3.13982190 |
| 43 | Dicarboxylic aciduria (HP:0003215) | 3.12342399 |
| 44 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.12342399 |
| 45 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.11130589 |
| 46 | Metabolic alkalosis (HP:0200114) | 3.04174635 |
| 47 | Pancreatic cysts (HP:0001737) | 3.03719277 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.03640206 |
| 49 | Abolished electroretinogram (ERG) (HP:0000550) | 3.02081760 |
| 50 | Pendular nystagmus (HP:0012043) | 2.99117822 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95100890 |
| 52 | Metabolic acidosis (HP:0001942) | 2.94781020 |
| 53 | Decreased central vision (HP:0007663) | 2.91729357 |
| 54 | Congenital sensorineural hearing impairment (HP:0008527) | 2.90783556 |
| 55 | Skin nodule (HP:0200036) | 2.87746071 |
| 56 | Congenital stationary night blindness (HP:0007642) | 2.87238642 |
| 57 | Myocardial infarction (HP:0001658) | 2.86850389 |
| 58 | Steatorrhea (HP:0002570) | 2.82237824 |
| 59 | Lethargy (HP:0001254) | 2.80905166 |
| 60 | Hepatocellular carcinoma (HP:0001402) | 2.79443750 |
| 61 | True hermaphroditism (HP:0010459) | 2.77948360 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.77327218 |
| 63 | Increased corneal curvature (HP:0100692) | 2.76717464 |
| 64 | Keratoconus (HP:0000563) | 2.76717464 |
| 65 | Spontaneous abortion (HP:0005268) | 2.75088524 |
| 66 | Abnormality of purine metabolism (HP:0004352) | 2.72683099 |
| 67 | Cerebral edema (HP:0002181) | 2.72054044 |
| 68 | Agitation (HP:0000713) | 2.68178142 |
| 69 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.66787195 |
| 70 | Myotonia (HP:0002486) | 2.64105521 |
| 71 | Hypochromic microcytic anemia (HP:0004840) | 2.63845457 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.61956681 |
| 73 | Acanthocytosis (HP:0001927) | 2.60232101 |
| 74 | Abnormality of the nasal septum (HP:0000419) | 2.59979796 |
| 75 | Abnormality of the renal cortex (HP:0011035) | 2.58002629 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.57964215 |
| 77 | Vascular calcification (HP:0004934) | 2.48556154 |
| 78 | Short 4th metacarpal (HP:0010044) | 2.48455706 |
| 79 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.48455706 |
| 80 | Muscle fiber inclusion bodies (HP:0100299) | 2.48137580 |
| 81 | Short femoral neck (HP:0100864) | 2.47011195 |
| 82 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.45942043 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.45113812 |
| 84 | Abnormal gallbladder morphology (HP:0012437) | 2.44036745 |
| 85 | Gout (HP:0001997) | 2.43341372 |
| 86 | Cholelithiasis (HP:0001081) | 2.40609508 |
| 87 | Osteomalacia (HP:0002749) | 2.35032181 |
| 88 | Methylmalonic acidemia (HP:0002912) | 2.34689491 |
| 89 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.34319370 |
| 90 | Hyperventilation (HP:0002883) | 2.33750399 |
| 91 | Chorioretinal atrophy (HP:0000533) | 2.32796060 |
| 92 | Type 1 muscle fiber predominance (HP:0003803) | 2.32379784 |
| 93 | Cholecystitis (HP:0001082) | 2.31411068 |
| 94 | Abnormal gallbladder physiology (HP:0012438) | 2.31411068 |
| 95 | Short tibia (HP:0005736) | 2.31049610 |
| 96 | Nephronophthisis (HP:0000090) | 2.29943228 |
| 97 | Mesomelia (HP:0003027) | 2.29561586 |
| 98 | Nemaline bodies (HP:0003798) | 2.29247617 |
| 99 | Renal cortical cysts (HP:0000803) | 2.27599997 |
| 100 | Pigmentary retinal degeneration (HP:0001146) | 2.27347689 |
| 101 | Vomiting (HP:0002013) | 2.25508265 |
| 102 | Congenital, generalized hypertrichosis (HP:0004540) | 2.25500048 |
| 103 | Spastic diplegia (HP:0001264) | 2.25349497 |
| 104 | Absent phalangeal crease (HP:0006109) | 2.24966820 |
| 105 | Irritability (HP:0000737) | 2.24632981 |
| 106 | Syncope (HP:0001279) | 2.23945952 |
| 107 | Methylmalonic aciduria (HP:0012120) | 2.23865464 |
| 108 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23277827 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.22870771 |
| 110 | Neonatal onset (HP:0003623) | 2.22097215 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.21580166 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.21580166 |
| 113 | Cardiovascular calcification (HP:0011915) | 2.21236133 |
| 114 | Abnormality of midbrain morphology (HP:0002418) | 2.21115464 |
| 115 | Molar tooth sign on MRI (HP:0002419) | 2.21115464 |
| 116 | Glomerulonephritis (HP:0000099) | 2.21044911 |
| 117 | Alkalosis (HP:0001948) | 2.20542144 |
| 118 | Mitral stenosis (HP:0001718) | 2.20519409 |
| 119 | Pancreatitis (HP:0001733) | 2.19125615 |
| 120 | Esophageal varix (HP:0002040) | 2.18105676 |
| 121 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.17834467 |
| 122 | Malnutrition (HP:0004395) | 2.17833656 |
| 123 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.14559725 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 2.14443923 |
| 125 | Abnormality of renin-angiotensin system (HP:0000847) | 2.13299656 |
| 126 | Enlarged kidneys (HP:0000105) | 2.13256395 |
| 127 | Brushfield spots (HP:0001088) | 2.11310214 |
| 128 | Late onset (HP:0003584) | 2.11253422 |
| 129 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.11139321 |
| 130 | Abnormality of the renal collecting system (HP:0004742) | 2.10306190 |
| 131 | Abnormality of the renal medulla (HP:0100957) | 2.08557422 |
| 132 | Visual hallucinations (HP:0002367) | 2.08366005 |
| 133 | Proximal tubulopathy (HP:0000114) | 2.07254332 |
| 134 | Goiter (HP:0000853) | 2.06188666 |
| 135 | Amyloidosis (HP:0011034) | 2.04473509 |
| 136 | Cystic liver disease (HP:0006706) | 2.03964601 |
| 137 | Myoglobinuria (HP:0002913) | 2.03701448 |
| 138 | Mesangial abnormality (HP:0001966) | 2.03489192 |
| 139 | Ventricular fibrillation (HP:0001663) | 2.03333247 |
| 140 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01222585 |
| 141 | Poikilocytosis (HP:0004447) | 2.00401483 |
| 142 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99730579 |
| 143 | Abnormality of alanine metabolism (HP:0010916) | 1.99730579 |
| 144 | Hyperalaninemia (HP:0003348) | 1.99730579 |
| 145 | Gingival bleeding (HP:0000225) | 1.99310137 |
| 146 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.98934380 |
| 147 | Abnormality of the 4th metacarpal (HP:0010012) | 1.98299140 |
| 148 | Hemorrhage of the eye (HP:0011885) | 1.97868203 |
| 149 | Furrowed tongue (HP:0000221) | 1.97542546 |
| 150 | Abnormality of the gallbladder (HP:0005264) | 1.96525189 |
| 151 | Decreased subcutaneous fat (HP:0001002) | 1.96089139 |
| 152 | Cerebral palsy (HP:0100021) | 1.95508634 |
| 153 | Hyperglycemia (HP:0003074) | 1.94959481 |
| 154 | Hemiplegia (HP:0002301) | 1.93037101 |
| 155 | Gaze-evoked nystagmus (HP:0000640) | 1.92982841 |
| 156 | Chronic hepatic failure (HP:0100626) | 1.92588311 |
| 157 | Abnormal cartilage morphology (HP:0002763) | 1.92211570 |
| 158 | Clumsiness (HP:0002312) | 1.92176654 |
| 159 | Hypokalemia (HP:0002900) | 1.91856227 |
| 160 | Menorrhagia (HP:0000132) | 1.91797100 |
| 161 | Prolonged QT interval (HP:0001657) | 1.91734418 |
| 162 | Abnormality of binocular vision (HP:0011514) | 1.91507298 |
| 163 | Diplopia (HP:0000651) | 1.91507298 |
| 164 | Glycosuria (HP:0003076) | 1.90646911 |
| 165 | Abnormality of urine glucose concentration (HP:0011016) | 1.90646911 |
| 166 | Abnormal finger flexion creases (HP:0006143) | 1.90112342 |
| 167 | Nausea (HP:0002018) | 1.89892326 |
| 168 | Thrombophlebitis (HP:0004418) | 1.89217980 |
| 169 | Elevated hepatic transaminases (HP:0002910) | 1.88004643 |
| 170 | Tubular atrophy (HP:0000092) | 1.87569638 |
| 171 | Attenuation of retinal blood vessels (HP:0007843) | 1.87407527 |
| 172 | Abnormality of the calf musculature (HP:0001430) | 1.86535575 |
| 173 | Type II lissencephaly (HP:0007260) | 1.86425619 |
| 174 | Abnormality of potassium homeostasis (HP:0011042) | 1.86209263 |
| 175 | Radial bowing (HP:0002986) | 1.85646733 |
| 176 | Opisthotonus (HP:0002179) | 1.85446296 |
| 177 | Rickets (HP:0002748) | 1.84838176 |
| 178 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.84537717 |
| 179 | Conjunctival hamartoma (HP:0100780) | 1.84086294 |
| 180 | Hyperuricemia (HP:0002149) | 1.82805287 |
| 181 | Increased purine levels (HP:0004368) | 1.82805287 |
| 182 | Acute hepatic failure (HP:0006554) | 1.81918372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.14857294 |
| 2 | SIK1 | 4.35852814 |
| 3 | FGFR4 | 3.92203224 |
| 4 | ERN1 | 3.69997879 |
| 5 | INSRR | 3.27358715 |
| 6 | TLK1 | 3.06175259 |
| 7 | ADRBK2 | 2.92475035 |
| 8 | ERBB4 | 2.62163121 |
| 9 | TAOK3 | 2.57295090 |
| 10 | WNK4 | 2.55304127 |
| 11 | PKN2 | 2.35354282 |
| 12 | TRIB3 | 2.34867773 |
| 13 | MST1R | 2.09369368 |
| 14 | ACVR1B | 2.06314584 |
| 15 | MAP2K4 | 1.99925640 |
| 16 | BMPR1B | 1.99414583 |
| 17 | PRKD2 | 1.98309803 |
| 18 | LATS1 | 1.82824466 |
| 19 | MAPK11 | 1.77111953 |
| 20 | STK39 | 1.75734897 |
| 21 | FLT3 | 1.70949920 |
| 22 | PIK3CG | 1.68552372 |
| 23 | PDK3 | 1.52348207 |
| 24 | PDK4 | 1.52348207 |
| 25 | PRKAA2 | 1.51609174 |
| 26 | WNK3 | 1.48082291 |
| 27 | FRK | 1.46716939 |
| 28 | PINK1 | 1.46041873 |
| 29 | TYK2 | 1.43371622 |
| 30 | CAMK1D | 1.39383325 |
| 31 | NEK9 | 1.39148576 |
| 32 | MAPK13 | 1.38054102 |
| 33 | CASK | 1.37413184 |
| 34 | ABL2 | 1.36604337 |
| 35 | MAP3K7 | 1.26896502 |
| 36 | DAPK2 | 1.25735825 |
| 37 | PTK6 | 1.25257993 |
| 38 | FGFR2 | 1.22485103 |
| 39 | KDR | 1.22390820 |
| 40 | TIE1 | 1.19559823 |
| 41 | MAPKAPK3 | 1.19554992 |
| 42 | MUSK | 1.18848956 |
| 43 | STK38L | 1.13438589 |
| 44 | JAK2 | 1.11999695 |
| 45 | CAMKK2 | 1.09221785 |
| 46 | ADRBK1 | 1.09197672 |
| 47 | OXSR1 | 1.08717958 |
| 48 | NTRK3 | 1.08104294 |
| 49 | JAK1 | 1.04740831 |
| 50 | TXK | 0.98536490 |
| 51 | MAP2K3 | 0.98198095 |
| 52 | NLK | 0.94678231 |
| 53 | PRKAA1 | 0.93646473 |
| 54 | TBK1 | 0.91954848 |
| 55 | MAP4K2 | 0.91388853 |
| 56 | MAPKAPK5 | 0.90093354 |
| 57 | ERBB2 | 0.89395512 |
| 58 | MAPK12 | 0.87165785 |
| 59 | PRKCG | 0.86690740 |
| 60 | RIPK1 | 0.84716282 |
| 61 | MAP3K10 | 0.84608662 |
| 62 | MAP3K3 | 0.84264741 |
| 63 | PRKACG | 0.83638279 |
| 64 | MARK1 | 0.82588211 |
| 65 | SGK3 | 0.81768482 |
| 66 | NTRK2 | 0.80716137 |
| 67 | RPS6KA6 | 0.80526693 |
| 68 | MAP3K14 | 0.80148995 |
| 69 | PIK3CA | 0.79468806 |
| 70 | MET | 0.78877054 |
| 71 | PDK2 | 0.78292039 |
| 72 | PRKACA | 0.78180719 |
| 73 | CAMK1 | 0.78128714 |
| 74 | GRK7 | 0.77637357 |
| 75 | PRKCZ | 0.77231314 |
| 76 | CAMK1G | 0.76445451 |
| 77 | SGK1 | 0.75128537 |
| 78 | EPHA3 | 0.75054303 |
| 79 | EPHB1 | 0.74050800 |
| 80 | GRK6 | 0.71829653 |
| 81 | CDK6 | 0.71496559 |
| 82 | NUAK1 | 0.70095003 |
| 83 | PDPK1 | 0.69686102 |
| 84 | OBSCN | 0.69518576 |
| 85 | TGFBR2 | 0.67919134 |
| 86 | MAP3K4 | 0.67803077 |
| 87 | MYLK | 0.67576845 |
| 88 | CAMK2A | 0.67331669 |
| 89 | IRAK3 | 0.67285283 |
| 90 | DYRK2 | 0.67276404 |
| 91 | CAMK2G | 0.66996402 |
| 92 | SGK2 | 0.65763391 |
| 93 | PRKCE | 0.65266084 |
| 94 | GSK3A | 0.64832022 |
| 95 | STK11 | 0.64694940 |
| 96 | FGFR3 | 0.61423920 |
| 97 | RPS6KA2 | 0.59203140 |
| 98 | TYRO3 | 0.58098276 |
| 99 | MAP2K6 | 0.57918014 |
| 100 | WNK1 | 0.57552126 |
| 101 | MAP3K5 | 0.55039704 |
| 102 | MAPK7 | 0.55002740 |
| 103 | DYRK1B | 0.54795854 |
| 104 | CSK | 0.53827777 |
| 105 | PKN1 | 0.51338070 |
| 106 | LMTK2 | 0.50900459 |
| 107 | TRPM7 | 0.48979896 |
| 108 | PNCK | 0.48544288 |
| 109 | SGK223 | 0.48511756 |
| 110 | SGK494 | 0.48511756 |
| 111 | AKT3 | 0.47901188 |
| 112 | MAP2K1 | 0.47445400 |
| 113 | MAP3K11 | 0.47267334 |
| 114 | CSNK1A1 | 0.46699240 |
| 115 | PDK1 | 0.46675144 |
| 116 | GRK1 | 0.46614216 |
| 117 | DMPK | 0.46286013 |
| 118 | PRKCQ | 0.45941308 |
| 119 | IGF1R | 0.45905831 |
| 120 | STK16 | 0.45678704 |
| 121 | TGFBR1 | 0.45242079 |
| 122 | SIK2 | 0.44793859 |
| 123 | PRKG1 | 0.44447737 |
| 124 | RPS6KC1 | 0.43737106 |
| 125 | RPS6KL1 | 0.43737106 |
| 126 | PTK2B | 0.42470493 |
| 127 | * PRKCA | 0.42262295 |
| 128 | IKBKB | 0.41917006 |
| 129 | RET | 0.41851862 |
| 130 | MAPK15 | 0.41526056 |
| 131 | IKBKE | 0.41152403 |
| 132 | KIT | 0.41103648 |
| 133 | CAMK2D | 0.41082385 |
| 134 | MTOR | 0.39999872 |
| 135 | * MAPK4 | 0.39352809 |
| 136 | PTK2 | 0.38586648 |
| 137 | GRK5 | 0.38325746 |
| 138 | CDK4 | 0.38314125 |
| 139 | RPS6KA3 | 0.37925334 |
| 140 | CAMK4 | 0.37735017 |
| 141 | MAP3K6 | 0.37584673 |
| 142 | TTN | 0.37439063 |
| 143 | EPHB2 | 0.36882866 |
| 144 | PHKG1 | 0.36498096 |
| 145 | PHKG2 | 0.36498096 |
| 146 | PRKCH | 0.35853629 |
| 147 | PAK3 | 0.35520393 |
| 148 | RPS6KA5 | 0.34403799 |
| 149 | CSF1R | 0.33568567 |
| 150 | IRAK1 | 0.31402673 |
| 151 | PRKD1 | 0.31298562 |
| 152 | ICK | 0.31175868 |
| 153 | LATS2 | 0.28906079 |
| 154 | TAOK2 | 0.27903064 |
| 155 | IRAK2 | 0.27301039 |
| 156 | PDGFRA | 0.27182135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.21861758 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57663436 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23508199 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18898264 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.88126717 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.86715522 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74388758 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.71651303 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67476394 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.67143707 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.53319378 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.40529163 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35492601 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.29439696 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.18367138 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16515938 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.11684699 |
| 18 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02648554 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00114861 |
| 20 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83062794 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.82644423 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.79872859 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78364145 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78346384 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77013759 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67963972 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.67504958 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65076568 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63987487 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.62202348 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61712296 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59306209 |
| 33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.57154116 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56353594 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.55611754 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50293757 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.46913784 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44055887 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42608491 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 1.37166883 |
| 41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35557484 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.35093054 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34037481 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29437815 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.29150735 |
| 46 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24343644 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21829416 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.20883285 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19108061 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.18227487 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17074467 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.14905996 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.12450811 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06952273 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06506205 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02535086 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01371671 |
| 58 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.93982320 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.93840948 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93271440 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.92641153 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92520745 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92507211 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92010454 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.91210936 |
| 66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89693986 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89081127 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.87050497 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.86825299 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86270105 |
| 71 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84242291 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84026021 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.83605086 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82419292 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81876871 |
| 76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81232714 |
| 77 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78762341 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78421033 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72506804 |
| 80 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71285219 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.70820042 |
| 82 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69848294 |
| 83 | Taste transduction_Homo sapiens_hsa04742 | 0.68523240 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.66869204 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.66568344 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.64596369 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60888482 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59215276 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58872769 |
| 90 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.57588594 |
| 91 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.56960360 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52734866 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50506904 |
| 94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46944641 |
| 95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43779699 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43566011 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43327350 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40806779 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40063698 |
| 100 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38823812 |
| 101 | Melanoma_Homo sapiens_hsa05218 | 0.38245049 |
| 102 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.36373654 |
| 103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.33000911 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28580360 |
| 105 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27716109 |
| 106 | * Insulin resistance_Homo sapiens_hsa04931 | 0.27696155 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27322827 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27092592 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.26018782 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19990428 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18200827 |
| 112 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.14499387 |
| 113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14042409 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13933315 |
| 115 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09328500 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2411979 |
| 117 | Parkinsons disease_Homo sapiens_hsa05012 | -0.2410488 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2293996 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | -0.2290590 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2158790 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | -0.2144811 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2053941 |
| 123 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2021758 |
| 124 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1909460 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1821126 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1726780 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1682768 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1621401 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1584074 |
| 130 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1521910 |
| 131 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1512961 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1381192 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1233514 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0479534 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0037258 |

